BusinessElto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive ImpairmentBy Nasdaq OMXMay 1, 2018, 2:31 PM UTC
BusinessElto Pharma to Present and Participate in Neuroscience Panel at Sachs BioCapital USA ForumBy Nasdaq OMXMar 5, 2018, 1:04 PM UTC
